rs1053320

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001848.3(COL6A1):​c.2796C>T​(p.Ser932Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.288 in 1,612,542 control chromosomes in the GnomAD database, including 68,834 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.31 ( 7820 hom., cov: 35)
Exomes 𝑓: 0.29 ( 61014 hom. )

Consequence

COL6A1
NM_001848.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -4.25

Publications

21 publications found
Variant links:
Genes affected
COL6A1 (HGNC:2211): (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]
COL6A1 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bethlem myopathy 1A
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 21-46003722-C-T is Benign according to our data. Variant chr21-46003722-C-T is described in ClinVar as Benign. ClinVar VariationId is 93870.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.25 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.404 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A1NM_001848.3 linkc.2796C>T p.Ser932Ser synonymous_variant Exon 35 of 35 ENST00000361866.8 NP_001839.2 P12109A0A384P5H7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A1ENST00000361866.8 linkc.2796C>T p.Ser932Ser synonymous_variant Exon 35 of 35 1 NM_001848.3 ENSP00000355180.3 P12109

Frequencies

GnomAD3 genomes
AF:
0.312
AC:
47410
AN:
152144
Hom.:
7813
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.410
Gnomad AMI
AF:
0.167
Gnomad AMR
AF:
0.313
Gnomad ASJ
AF:
0.220
Gnomad EAS
AF:
0.159
Gnomad SAS
AF:
0.196
Gnomad FIN
AF:
0.251
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.289
Gnomad OTH
AF:
0.283
GnomAD2 exomes
AF:
0.267
AC:
66141
AN:
247462
AF XY:
0.261
show subpopulations
Gnomad AFR exome
AF:
0.406
Gnomad AMR exome
AF:
0.287
Gnomad ASJ exome
AF:
0.218
Gnomad EAS exome
AF:
0.147
Gnomad FIN exome
AF:
0.250
Gnomad NFE exome
AF:
0.287
Gnomad OTH exome
AF:
0.255
GnomAD4 exome
AF:
0.286
AC:
417096
AN:
1460280
Hom.:
61014
Cov.:
44
AF XY:
0.282
AC XY:
204625
AN XY:
726430
show subpopulations
African (AFR)
AF:
0.414
AC:
13844
AN:
33474
American (AMR)
AF:
0.286
AC:
12767
AN:
44632
Ashkenazi Jewish (ASJ)
AF:
0.220
AC:
5736
AN:
26110
East Asian (EAS)
AF:
0.182
AC:
7234
AN:
39688
South Asian (SAS)
AF:
0.206
AC:
17802
AN:
86240
European-Finnish (FIN)
AF:
0.250
AC:
13109
AN:
52354
Middle Eastern (MID)
AF:
0.214
AC:
1237
AN:
5768
European-Non Finnish (NFE)
AF:
0.296
AC:
329225
AN:
1111654
Other (OTH)
AF:
0.267
AC:
16142
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
21437
42873
64310
85746
107183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10890
21780
32670
43560
54450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.312
AC:
47448
AN:
152262
Hom.:
7820
Cov.:
35
AF XY:
0.309
AC XY:
22999
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.409
AC:
17012
AN:
41562
American (AMR)
AF:
0.313
AC:
4789
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.220
AC:
765
AN:
3472
East Asian (EAS)
AF:
0.160
AC:
826
AN:
5176
South Asian (SAS)
AF:
0.196
AC:
947
AN:
4828
European-Finnish (FIN)
AF:
0.251
AC:
2664
AN:
10602
Middle Eastern (MID)
AF:
0.194
AC:
57
AN:
294
European-Non Finnish (NFE)
AF:
0.289
AC:
19644
AN:
67998
Other (OTH)
AF:
0.280
AC:
592
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1763
3526
5290
7053
8816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.297
Hom.:
4713
Bravo
AF:
0.321
Asia WGS
AF:
0.176
AC:
617
AN:
3478
EpiCase
AF:
0.281
EpiControl
AF:
0.278

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 17, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 22, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Bethlem myopathy 1A Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Collagen 6-related myopathy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Ullrich congenital muscular dystrophy 1A Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.038
DANN
Benign
0.73
PhyloP100
-4.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1053320; hg19: chr21-47423636; COSMIC: COSV62612170; COSMIC: COSV62612170; API